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Abstract: 
Background. Females experience a disproportionate number of anterior cruciate ligament 
injuries compared to males. Increased estradiol concentration has been suggested to alter 
ligament properties and strength. Determining whether the knee responds differently to an 
external load at various hormonal levels may be helpful in further explaining the gender 
disparity. 
 
Methods. Estradiol, progesterone and testosterone were quantified at menses, near ovulation and 
at the mid-luteal phase. With one knee serving as the control limb and the other as the 
experimental limb, displacement at 134N and stiffness between 90 and 134N were recorded with 
a knee ligament arthrometer on both knees before and after a loading protocol. The protocol 
consisted of three, 3-min, posterior to anterior normalized loads directed to the posterior calf 
with a ligament testing device. 
 
Findings. The loading protocol produced a measurable increase in displacement but not 
stiffness. Neither displacement nor stiffness measures however were affected by day of the 
menstrual cycle. No consistent relationships between hormonal concentrations and displacement 
or stiffness were evident. 
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Interpretation. Following a controlled, static external load, displacement and stiffness were not 
affected differently by day of the menstrual cycle. 
 




Despite meticulous research efforts over the last decade, females continue to experience a 
disproportionate number of anterior cruciate ligament (ACL) injuries compared to males (Arendt 
et al., 1999; Gwinn et al., 2000). To assist with explaining the disparity, identified risk factors 
have been classified as anatomical, environmental, neuromuscular and hormonal (Griffin et al., 
2000). Some work (Wojtys et al., 2002) has suggested the ACL may be predisposed to greater 
injury risk during elevated hormone concentrations, specifically estradiol. At the basic science 
level, estrogen receptors on the ACL have been identified (Liu et al., 1996). Further study 
revealed a dose dependent decrease in fibroblast proliferation with increasing concentrations of 
estradiol (Liu et al., 1997). These results suggest the structural integrity of the ACL may be 
compromised at higher concentrations of estradiol. Supporting this premise, research has 
identified a decrease in the tensile strength of the ACL in a group of ovarectomized rabbits 
exposed to estrogen for a one-month period of time compared to a control group (Slauterbeck et 
al., 1999). More recently, a multi-center prospective epidemiologic study (Wojtys et al., 2002) 
identified females were more likely to experience a non-contact ACL injury during the ovulatory 
phase of their menstrual cycle compared to the follicular or luteal phases. 
 
Collectively, these studies suggest that the manner in which the knee is affected by an external 
load is at least partially dependent upon estradiol concentrations. In fact, some work has 
identified increases in anterior tibiofemoral displacement (Heitz et al., 1999; Shultz et al., 2004) 
and decreases in `ACL stiffness' (Romani et al.,2003) with elevated concentrations of estradiol. 
Though important, the aforementioned works solely measured displacement and stiffness at 
different points throughout the menstrual cycle. These studies do not provide insight on how the 
tibiofemoral joint responds following a loading protocol targeting the structures that restrain 
anterior tibiofemoral displacement. While unknown, it is plausible that these structures, 
particularly the ACL, are affected differently following the application of an external load during 
periods when estradiol concentrations are elevated. 
 
We were unable to identify any published studies that examined the effect of an external load on 
knee ligament behavior at various hormonal concentrations in females. Therefore, the purpose of 
our study was to evaluate the effects of a controlled anterior tibiofemoral load on passive anterior 
tibiofemoral displacement and stiffness in a group of healthy females across select points of the 
menstrual cycle. We hypothesized that following a standardized loading protocol, anterior 
tibiofemoral displacement would increase and anterior tibiofemoral stiffness would decrease to a 
greater extent at time points in the menstrual cycle associated with higher concentrations of 




Twenty healthy, recreationally active (hours engaged in exercise per week, 4.0 (SD, 3.0)) 
females (age, 20.9 (SD, 1.6 years); height, 1.6 (SD, .07m); mass, 59.6 (SD, 7.4kg)) between the 
ages of 18 and 26 were recruited from the University community. An a priori power analysis for 
displacement and stiffness was calculated based on data available from the literature (Heitz et al., 
1999; Nawata et al., 1999). With effect sizes of 0.98 and 1.00 for displacement and stiffness 
respectively, inclusion of 20 subjects was expected to yield a power of 85%. Inclusion criteria 
included: (1) normal menstrual cycle lasting 28–32 days for the past six months; (2) no history of 
pregnancy; (3) no use of oral contraceptive or other hormone stimulating medications for the past 
six months; (4) healthy knees bilaterally and (5) no known co-existing medical conditions 
affecting the connective tissue. Prior to testing, all participants read and signed an informed 
consent form approved by the University's Human Investigations Committee. 
 
Experimental setting and design 
All data were collected at the General Clinical Research Center (GCRC) at the University Health 
Sciences Center. Participants reported for testing within 36 h following three occasions: (1) 
menses; (2) near ovulation and (3) during the mid-luteal phase. Menses (M) was defined by the 
onset of menstrual bleeding as reported by the participant; near ovulation (O) was identified by a 
positive test detected with a commercially available urine ovulation kit (CVS Pharmacy Inc.; 
Woonsocket, RI, USA) and the mid-luteal phase (L) was predicted by having the participant 
subtract eight days from the expected end of their current cycle (Michaud et al., 1999). The 
timing of each visit was strategically selected to assess knee ligament behavior at the peaks and 
valleys of various hormonal levels. Menses was intended to represent the period when both 
estradiol (E2) and progesterone (P) concentrations were low. Near ovulation was selected in an 
effort to capture peak estradiol levels while progesterone concentration remained low and the 
mid-luteal phase was chosen to detect the surge in progesterone while estradiol levels remained 
elevated. 
 
With the assistance of a co-investigator, participants initiated the study by contacting the 
principal investigator at one of the three menstrual cycle events. This process ensured the 
principal investigator was blinded to the participant's day of the menstrual cycle. Both knees 
were used for the study with one knee serving as the control and the other as the experimental. 
As participants were enrolled in the study, control and experimental sides were counterbalanced 
by limb dominance. Limb dominance was defined as the leg a participant would use to kick a 
ball. 
 
Instrumentation and procedures 
The same procedures were followed each test session. All participants refrained from physical 
activity on the day of testing until after each session had been completed. Upon reporting for 
testing, 5–7cc of venous blood was drawn to quantify serum hormone levels of estradiol, 
progesterone as well as testosterone. Testosterone (T) was analyzed not only to gain a broader 
depiction of each participant's hormonal environment but also to ensure our participants had 
stable and normal circulating levels of this endogenous hormone. 
 
Next, the KT-2000TM (MEDmetric Corp.®; San Diego, CA, USA) knee joint arthrometer with 
an attached masonry bubble level (Stanley Works; New Britain, CT, USA) was used per 
manufacturer's instructions with the knee in 30° of flexion to record three pre-measures of 
anterior tibiofemoral displacement at 134N bilaterally. All knee arthrometer measures were per-
formed by the principal investigator with a previously established intra-rater reliability (ICC[2,k] 
(SEM)) of 0.97 (0.37mm) for displacement. Raw force and displacement data were acquired with 
the CompuKT® software (MEDmetric Corp.®) and stored on a personal computer. 
 
Following the pre-measures, while the control limb remained relaxed in a non-weight-bearing 
posture, a standardized, static loading protocol with the knee in 30° of flexion was performed on 
the experimental side. The loading protocol consisted of three, 3-min, posterior to anterior 
normalized static loads directed to the posterior calf, 10 cm inferior to the joint line with the 
LigMaster testing device (Sport Tech, Inc., Charlottesville, VA, USA) (Fig. 1). This device 
allowed continuous digital readouts of the applied force while the loading protocol was 
performed. The applied load or force was normalized to body weight and tibia length and cal-
culated using a static moment equation: 
 
The quantity of force utilized with the loading protocol was selected based on the results of other 
published work (Henning et al., 1985) and pilot testing. Pilot testing indicated a load of 18% 
body weight was sufficient to 
 
Fig. 1. Participant in standardized position within the Ligmaster  Ligament Testing Device. 
 
produce a measurable increase in displacement. Furthermore, this quantity of load was close to 
the maximum load that a subject could reasonably tolerate during the loading protocol. Once 
applied, the load was closely monitored and adjusted as necessary to ensure a constant force for 
the entire trial. Immediately following the loading protocol, post-measures of anterior tibio-
femoral displacement using identical procedures as the pre-measures were recorded bilaterally. 
 
Data reduction 
Blood assays were analyzed at the GCRC Core Lab. Specifically, progesterone and testosterone 
were analyzed using a chemiluminescence assay and estradiol by Solid-Phase RIA 
(radioimmunoassay). Raw data (force and displacement) were exported from the CompuKT® 
software as a text file (.txt) and imported into ExcelTM where displacement and stiffness values 
were calculated. For displacement and stiffness data, an average of the three trials was used for 
data analysis. Displacement was defined as the amount of anterior tibial translation at 134N of 
force expressed in millimeters. Stiffness (N/mm) was defined as the change in force divided by 
the change in displacement between 90 and 134N. 
 
Statistical analysis 
All data were analyzed with SPSS® Version 10.0. Separate repeated measures analysis of 
variances (ANOVAs) were utilized to determine if significant differences in estradiol, 
progesterone and testosterone levels existed between the days of the menstrual cycle. Repeated 
measures ANOVAs with three within variables (loading [pre, post], side [control, experimental] 
and menstrual cycle day [menses, ovulatory, mid-luteal]) were used to analyze displacement 
(134N) and stiffness (90–134N) data. Post-hoc testing as necessary (P < 0.05) was performed 
with Tukey's Honestly Significant Difference test. Pearson correlation coefficients were 




Tables 1 and 2 provide descriptive statistics for hormonal concentrations and the dependent 
measures of displacement and stiffness before and after the loading protocol. On average, 145N 
(SD, 18; range, 114–184N) of force was applied to the subject's posterior calf with the Ligmaster 
Testing Device during the loading protocol. While concentration levels of estradiol and 





(E2L = E2O > E2M; PL > PO = PM), there were no differences in concentrations of testosterone (P 
= 0.11). We did not observe differences in displacement (P = 0.40) or stiffness (P = 0.36) when 
menstrual cycle days were compared. We found a significant interaction between load and 
displacement (P = 0.009) (Fig. 2) with displacement being greater on the experimental side when 
compared to the control following the loading protocol. This 
 
Fig. 2. Averaged across all days, post-loading, displacement (mm) on the experimental limb was greater than 
displacement on the control limb (P = 0.009). 
 
loading effect did not vary by day of the menstrual cycle for either displacement (P = 0.09) or 




The primary finding of our study was that following a controlled, static loading protocol, anterior 
tibiofemoral displacement and stiffness did not significantly vary across the selected days of the 
menstrual cycle. When menstrual cycle days were collapsed, a difference between experimental 
and control limbs was evident for displacement following the loading protocol. Additionally, the 
strength of the correlation coefficients between displacement and stiffness measures and 
menstrual cycle day were similar between test days. 
 
Effect of cycle day on ligament behavior post-loading 
Our findings as they relate to displacement post-loading at select points across the menstrual 
cycle are consistent with those recently reported by Pollard et al. (2003). In both our study and 
that by Pollard et al., two important similarities are evident. 
 
 
First, a significant difference between control and experimental limbs for displacement was 
noted after the loading protocol, regardless of cycle day. In our study, the significant difference 
appears to be the result of a concomitant increase in displacement on the experimental side and a 
slight decrease in displacement on the control side (Fig. 2). The decrease in displacement 
observed on the control side may be a function of inactivity during the testing period. A decrease 
in tissue temperature (i.e. cooling from the inactivity) may have played a factor with the 
observed decrease in displacement though this is only speculative as we did not measure 
temperature. 
 
Secondly, a significant rise in estradiol from menses to near ovulation was noted. This context is 
important as it is hypothesized that a rise in estradiol concentration is a prerequisite to initiate the 
cascade of events that compromise the structural integrity of the ACL (Liu et al., 1997). Though 
our findings are in agreement, methodologies were substantially different between the two 
studies. While Pollard et al. used a weight-bearing functional exercise model, we chose a non-
weight bearing, controlled loading model. We purposely selected this model to ensure the 
applied moment was consistent from one test session to the next. Therefore, despite considerable 
differences in methodology, both studies failed to identify differences in displacement between 
days of the menstrual cycle following a protocol that stressed the passive structures that restrain 
anterior tibial translation. 
 
While important, displacement measures alone do not adequately describe ligament behavior. 
The description of ligament behavior can be enhanced by the addi tion of stiffness measures. 
Stiffness represents the ease at which a material can be deformed. A stiff tissue requires a 
substantial quantity of force to cause changes in displacement whereas a more compliant or less 
stiff tissue requires significantly less force to cause a change in displacement. Following the 
loading protocol and contrary to our hypothesis, stiffness measures whether examined 
collectively or by menstrual cycle day were similar. Given the inherent relationship between 
displacement and stiffness, it is reasonable to expect that a change in displacement will be 
accompanied by a change in stiffness. Our findings of an increase in displacement but no 
difference in stiffness are not novel (Deie et al., 2002) and are likely due to either statistical or 
methodological phenomenon. Statistically, the stiffness data variability may have precluded 
identifying differences. From a methods standpoint, differences in stiffness may have been 
present at a lower force interval (i.e. 44–89N) of the stress–strain curve thereby resulting in an 
increase in displacement with no apparent increase in stiffness. 
 
Overall, these findings suggest that ligament behavior, as defined by displacement and stiffness 
measures, do not vary appreciably across the menstrual cycle following the application of an 
external load. 
 
Effect of cycle day on displacement 
Overall, we did not observe differences in anterior tibiofemoral displacement across the days of 
the menstrual cycle tested. In fact, the maximum difference between overall means (near 
ovulation [5.68] — mid-luteal [5.50]) was only 0.18 mm. This is in agreement with some work 
(Beynnon, 2003; Pollard et al., 2003) yet in conflict with others (Shultz et al., 2003; Deie et al., 
2002; Karageanes et al., 2000; Heitz et al., 1999). Of those studies that did find a difference in 
displacement between phases of the menstrual cycle, only Heitz et al. reported absolute hormone 
levels. Like Beynnon et al. (171.4 pg/mL), our mean estradiol level near ovulation (123.1 
pg/mL) was dramatically lower than levels reported by Heitz et al. (778 pg/mL). It is possible 
that a concentration threshold for estradiol exists before increases in displacement can be 
observed and that our concentrations fell below this theoretical threshold. Furthermore, recent 
work from our laboratory (Shultz et al., 2004) reported the largest increase in displacement 
occurred at the beginning of the luteal phase, after the attainment of peak levels of estradiol yet 
before the rise in progesterone. These results suggest that it is only after several days of exposure 
to elevated estradiol levels that alterations in displacement are clinically evident. Given the 
conflicting findings related to displacement across the menstrual cycle, additional work 
emphasizing frequent if not daily measurement is necessary to clarify this issue. 
 
Effect of cycle day on stiffness 
Similar to displacement, we did not detect overall differences in stiffness between 90 and 134N 
across the three days tested. As can be discerned from Table 2, the differences between our mean 
stiffness values by day of the menstrual cycle were remarkably small. Adding to this, there was 
considerable inter-subject variation in stiffness quantified in this range, as noted by the large 
standard deviations. However, our mean values, small differences between days of the menstrual 
cycle and large inter-subject variability are consistent with previously reported studies (Romani 
et al., 2003; Shultz et al., 2003). At comparable estradiol levels, Romani et al. (2003) did not 
detect differences in passive anterior tibiofemoral stiffness as a function of menstrual cycle 
phase. Likewise, using a total of 15 days (five days to represent each of the menstrual cycle 
phases) across one cycle, preliminary results from Shultz et al. (2003) did not identify 
differences in passive anterior tibiofemoral stiffness measures. Each of these works used the KT-
2000 at 30° of knee flexion and measured stiffness between 89 and 134N in healthy normally 
menstruating female participants. Collectively, these reports imply stiffness does not differ 
appreciably across days of the menstrual cycle, although considerable variability exists between 
subjects. 
 
Hormonal–ligament behavior relationship 
Our findings are in contrast to those reported by Romani et al. (2003), who reported a significant 
inverse relationship between estradiol and `ACL stiffness' near ovulation. These conflicting 
findings are likely explained by methodologic and statistical differences. Romani et al. 
investigated the influence of multiple endogenous hormones on `ACL stiffness'. The authors 
were particularly interested in the relationship between estradiol and `ACL stiffness'. To account 
for the interactive effect among the multiple hormones on `ACL stiffness', the authors used 
partial correlations. Partial correlations likely assisted with identifying this significant relation-
ship by accounting for the influence of other hormones. Despite the identified inverse 
relationship between `ACL stiffness' and estradiol near ovulation, it is interesting to note that the 
authors did not detect a mean difference in stiffness values between menstrual cycle phases. 
Additional research is necessary to further elucidate these relationships. 
 
Study limitations 
Like all studies, our work does present with some limitations. As we placed several constraints 
on our study to minimize the influence of extraneous variables, our results can only be 
generalized to the specific loading protocol utilized, measured hormones, and the examined 
dependent measures. Our findings do not provide insight as to whether the response would have 
been similar under different loading conditions. As in vivo forces during sport activity occur 
more rapidly and in a repetitive fashion, a controlled model that produces faster applications of 
force in a cyclical manner is worthy of pursuit. While the findings of Pollard et al. do not support 
this contention, their work despite a standardized exercise protocol did not strictly control the 
applied moment at the tibiofemoral joint from one test session to the next. 
 
Also, our study only examined the effects of loading on displacement and stiffness as it related to 
the concentrations of three endogenous hormones. Certainly, we appreciate there are numerous 
hormones simultaneously circulating and interacting within the female hormonal environment. 
However, we chose to examine only those hormones that have been suspected to at least partially 
explain the high prevalence of non-contact female ACL injuries (Slauterbeck et al., 1999; Wojtys 
et al., 2002). Additionally, it is conceivable that we did not see changes in ligament behavior by 
days of the menstrual cycle as we may have failed to capture peak estradiol levels. Our mean 
estradiol value of 123 pg/mL near ovulation was below the expected range 150–258 pg/mL of 
estradiol for the ovulatory phase (Table 1). The likely failure to capture peak estradiol levels was 
influenced by the fact that we only measured hormone concentrations three times across the 
menstrual cycle. While these visits were strategically selected and an ovulation predictor was 
utilized, given the rapid rise and fall of estradiol, we may have missed this small window. 
Furthermore, more recent work (Shultz et al., 2004) has noted substantial variation in hormone 
fluctuations across the menstrual cycle, highlighting the importance of taking multiple 
measurements across the cycle to more accurately depict the rapidly changing hormonal 
environment. 
 
Future studies should quantify serum hormone concentrations while examining the effects of a 
cyclic, weight-bearing loading protocol with an emphasis on multiple measurements per cycle 
phase to clarify if displacement and stiffness measures are affected. Alternative populations 




Following a controlled, static non-weight-bearing loading protocol stressing the passive 
restraints that limit anterior tibiofemoral translation, displacement at 134N and stiffness between 
90 and 134N did not vary significantly between three select points across the menstrual cycle in 
a group of young healthy females. Overall, we failed to detect differences in displacement and 
stiffness measures by day of the menstrual cycle and likewise did not identify significant 
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